CLINICAL_TRIALS
trial_result
· 2023-07-03
Clinical Trial Update: Adolescent Mite Allergy Safety Evaluation [Phase 3]
Summary
Phase 3 safety evaluation for adolescents with mite allergy completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2023-07-03